Telephonic prompt
BehavioralOther names: Appended message
NCT Number: NCT02609035
ImmuSMART is a study of personalized telephonic prompts to community pharmacy patients to improve adult vaccination rates for pneumococcal and herpes zoster vaccines.
Looking for future studies?
Notify Me19 year and older
All sexes
Interventional
Not applicable
This study will investigate immunization rate improvement among adult patients in 250 northeastern US community pharmacies as a result of telephonic prompts during regular automated outbound communiqués. There will be three projects assessing different forms of these appended prompts-appointment-based medication synchronization automated prompts, refill ready automated prompts, and refill reminder automated prompts. Each intervention will occur in one of three pharmacy chains, each with approximately 10,000 patients randomized to control or intervention (receive prompt or no).
Prior to the outbound automated call to the patient, a third-party technology vendor (Scientific Technologies Corporation) will perform an automated immunization status assessment of the patient by submitting a query the state immunization registry to compare the adult patient's existing immunization record to the CDC Recommended Adult Immunization Schedule. Gaps in immunizations that fall within pharmacy scope of practice will be identified. During the automated call (performed by VoicePort, a pharmacy telephonic support vendor) to the patient, they will be prompted to receive identified immunization gap vaccines upon their next pharmacy visit, with priority on pneumococcal, influenza, and herpes zoster vaccinations. If the patient accepts, the vaccination will be delivered when next the patient comes to visit the pharmacy.
After 6 months of running the trial, statistical modeling will be employed to assess vaccination rate differences between control and intervention patients.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Other names: Appended message
Time frame: 3 months
Administration of vaccine will be assessed at 3 months after patient receives the prompt
Pharmacy Quality Alliance
Other
Acronym: ImmuSMART
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06802393
Disease Attributes, Emergencies
Buffalo, New York, United States
View Trial DetailsNCT06148142
Blood Pressure, Cost-effectiveness
Dhaka, Bangladesh
View Trial DetailsNCT01033279
Ambulatory Care, Anticoagulants
Montreal, Quebec, Canada
View Trial DetailsNCT06681142
Arthritis, Joint Diseases
Sherwood Park, Alberta, Canada
View Trial Details